Switch to:
Sanofi SA (NYSE:SNY)
Research and Development
$2,774 Mil (TTM As of Jun. 2015)

This is the expense the company spent on research and development. Sanofi SA's research and development for the three months ended in Jun. 2015 was $0 Mil. Its research and development for the trailing twelve months (TTM) ended in Jun. 2015 was $2,774 Mil.


Definition

This is the expense the company spent on research and development.

Sanofi SA Research & Development for the trailing twelve months (TTM) ended in Jun. 2015 was 1476.80412371 (Sep. 2014 ) + 0 (Dec. 2014 ) + 1297.61904762 (Mar. 2015 ) + 0 (Jun. 2015 ) = $2,774 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.


Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


Related Terms

Gross Profit


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Sanofi SA Annual Data

Dec05Dec06Dec07Dec08Dec09Dec10Dec11Dec12Dec13Dec14
Research & Development 4,7935,8526,6046,1826,6816,0156,3006,4376,5435,948

Sanofi SA Quarterly Data

Mar13Jun13Sep13Dec13Mar14Jun14Sep14Dec14Mar15Jun15
Research & Development 1,4991,5631,5781,7091,5751,6141,47701,2980
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GuruFocus Premium Plus Membership

FEEDBACK